Funding Received
$115.7 Million in 7 Rounds from 8 Investors
Most Recent Funding
$8.1 Million Grant on June 17, 2014
Headquarters:
Watertown, MA
Description:
Selecta Biosciences, a biopharmaceutical company, develops nanoparticle immunomodulatory drugs for the treatment and prevention of diseases.
Founders:
Ulrich von Andrian, Omid Farokhzad, Robert S. Langer
Categories:
Biotechnology
Website:
http://www.selectabio.com

Detailed Description

Update

Selecta Biosciences is a biopharmaceutical company developing the first generation of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Our proprietary product platform technology combines recent advances in immunobiology with cutting-edge nanotechnology to develop targeted immunomodulatory nanoparticles.

Current Team (9)

Update

Funding Rounds (7) - $115.7M

Update

Board Members and Advisors (8)

Update

Investors (8)

Update

Offices/Locations (1)

Update
  • Office

    480 Arsenal St

    Building One

    Watertown, MA 02472

    USA